KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Change in Inventory (2020 - 2025)

Historic Change in Inventory for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to $63.0 million.

  • Organon's Change in Inventory rose 327.87% to $63.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $125.0 million, marking a year-over-year decrease of 3523.32%. This contributed to the annual value of $131.0 million for FY2024, which is 4304.35% down from last year.
  • As of Q3 2025, Organon's Change in Inventory stood at $63.0 million, which was up 327.87% from $34.0 million recorded in Q2 2025.
  • Organon's Change in Inventory's 5-year high stood at $95.0 million during Q2 2022, with a 5-year trough of -$35.0 million in Q2 2021.
  • Its 5-year average for Change in Inventory is $42.8 million, with a median of $48.0 million in 2021.
  • The largest annual percentage gain for Organon's Change in Inventory in the last 5 years was 39677.42% (2021), contrasted with its biggest fall of 27500.0% (2021).
  • Organon's Change in Inventory (Quarter) stood at $48.0 million in 2021, then skyrocketed by 79.17% to $86.0 million in 2022, then grew by 8.14% to $93.0 million in 2023, then crashed by 66.67% to $31.0 million in 2024, then skyrocketed by 103.23% to $63.0 million in 2025.
  • Its Change in Inventory stands at $63.0 million for Q3 2025, versus $34.0 million for Q2 2025 and -$3.0 million for Q1 2025.